Another study showed that approximately 45% of small cell lung cancers and 50% of cell lines assessed were negative for ASS1 and ASS1-deficient small cell lung cancers were sensitive to ADI-PEG20 (pegylated arginine deiminase) (32). This evidence concerns the gene ASS1 and small cell lung carcinoma.